Home/Cingulate/Louise P. McCarthy
LP

Louise P. McCarthy

SVP, Regulatory Affairs & Quality Assurance

Cingulate

Therapeutic Areas

Cingulate Pipeline

DrugIndicationPhase
CTx-1301ADHDPhase 3
CTx-1302ADHDPhase 3
CTx-2103Anxiety DisordersPreclinical
CTx-2104Anxiety DisorderPreclinical
CTx-2105Anxiety DisorderPreclinical
CTx-2106Anxiety DisorderPreclinical